USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 190 filers reported holding USANA HEALTH SCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $205,369 | -6.2% | 3,504 | +0.9% | 0.06% | -3.0% |
Q2 2023 | $219,001 | +3.4% | 3,474 | +3.1% | 0.07% | -1.5% |
Q1 2023 | $211,847 | -16.9% | 3,368 | -4.5% | 0.07% | -19.3% |
Q2 2022 | $255,000 | -10.5% | 3,525 | -1.7% | 0.08% | +3.8% |
Q1 2022 | $285,000 | -59.0% | 3,585 | -50.2% | 0.08% | -16.7% |
Q4 2021 | $695,000 | +109.3% | 7,194 | +99.7% | 0.10% | +1.1% |
Q3 2021 | $332,000 | -7.5% | 3,603 | +2.7% | 0.10% | -7.8% |
Q2 2021 | $359,000 | +7.8% | 3,507 | +2.7% | 0.10% | +3.0% |
Q1 2021 | $333,000 | +25.2% | 3,416 | -0.8% | 0.10% | +16.3% |
Q4 2020 | $266,000 | -16.6% | 3,445 | -20.5% | 0.09% | -25.2% |
Q3 2020 | $319,000 | +5.3% | 4,336 | +5.2% | 0.12% | +4.5% |
Q2 2020 | $303,000 | +32.3% | 4,123 | +4.0% | 0.11% | +14.6% |
Q1 2020 | $229,000 | -25.6% | 3,966 | +1.1% | 0.10% | -11.9% |
Q4 2019 | $308,000 | +11.6% | 3,921 | -2.9% | 0.11% | +7.9% |
Q3 2019 | $276,000 | -26.6% | 4,039 | -14.7% | 0.10% | -27.3% |
Q2 2019 | $376,000 | -2.1% | 4,736 | +3.4% | 0.14% | -4.8% |
Q1 2019 | $384,000 | -25.6% | 4,581 | +4.6% | 0.15% | -33.0% |
Q4 2018 | $516,000 | -5.1% | 4,380 | -2.9% | 0.22% | +13.5% |
Q3 2018 | $544,000 | +3.8% | 4,511 | -0.7% | 0.19% | +1.1% |
Q2 2018 | $524,000 | +35.1% | 4,545 | +0.7% | 0.19% | +34.8% |
Q1 2018 | $388,000 | +39.6% | 4,515 | +20.4% | 0.14% | +39.6% |
Q4 2017 | $278,000 | +24.7% | 3,749 | +7.7% | 0.10% | +14.8% |
Q2 2017 | $223,000 | +7.7% | 3,481 | -2.9% | 0.09% | +6.0% |
Q1 2017 | $207,000 | -33.7% | 3,586 | -29.7% | 0.08% | -34.6% |
Q4 2016 | $312,000 | -14.8% | 5,102 | +92.9% | 0.13% | -13.0% |
Q3 2016 | $366,000 | +35.6% | 2,645 | +9.2% | 0.15% | +35.2% |
Q2 2016 | $270,000 | -44.7% | 2,423 | -39.7% | 0.11% | -44.6% |
Q1 2016 | $488,000 | -8.1% | 4,016 | -3.3% | 0.20% | -7.1% |
Q4 2015 | $531,000 | -5.2% | 4,153 | -0.6% | 0.21% | -7.1% |
Q3 2015 | $560,000 | -2.4% | 4,180 | -0.5% | 0.23% | +5.6% |
Q2 2015 | $574,000 | +20.8% | 4,201 | -1.7% | 0.21% | +20.2% |
Q1 2015 | $475,000 | +8.0% | 4,275 | -0.3% | 0.18% | +3.5% |
Q4 2014 | $440,000 | +31.7% | 4,290 | -5.5% | 0.17% | +33.3% |
Q3 2014 | $334,000 | -7.0% | 4,541 | -1.0% | 0.13% | -5.1% |
Q2 2014 | $359,000 | – | 4,589 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
RQSI Ltd | 3,937 | $404,000 | 0.38% |
CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |